ZTSZoetis
$74.80-49% 1Y
$74.80
$69.1152 weeks$145.76
ZTS in its own filings
Nothing in ZTS's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
283
Events found in the filings · across 2,066 filings · the record starts in 2012
- Hard flags
- none
Hard flags
- Most recent filing
- Oct 8, 2026
Most recent filing · Form 8-K
- Record starts
- Sep 11, 2012
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 3, 2026
- SEC comment-letter activity22 occurrences
- 2022-10-03
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 8, 2026Zoetis Declares Fourth Quarter 2026 Dividend.Regulation FD disclosure · press release
- Aug 6, 2026Zoetis Announces Second Quarter 2026 Results.Earnings release · press release
- Aug 6, 2026Appointment of James Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer On August 6, 2026, Zoetis Inc. (the “Company”) announced that James Saccaro has been appointed as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026.Director or officer change · Form 8-K
- May 22, 2026Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.Director or officer change · Form 8-K
- May 20, 2026Zoetis Declares Third Quarter 2026 Dividend.Regulation FD disclosure · press release
- May 7, 2026Zoetis Announces First Quarter 2026 Results.Earnings release · press release
- Feb 12, 2026Zoetis Reports Fourth Quarter and Full Year 2025 Results.Earnings release · press release
- Feb 5, 2026Zoetis Declares Second Quarter 2026 Dividend.Regulation FD disclosure · press release
- Dec 18, 2025Entry into a Material Agreement. Indenture and Notes On December 18, 2025, Zoetis Inc., a Delaware corporation (“Zoetis” or the “Company”), completed its previously announced private offering (the “Offering”) of 0.25% Convertible Senior Notes due 2029 (the “Notes”)Material agreement entered · Form 8-K
- Dec 11, 2025Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase.Regulation FD disclosure · press release
- Dec 2, 2025Zoetis Inc. (the “Company”) will host an Innovation Webcast at 8:30 a.m. ET on Tuesday, December 2, 2025.Other event · Form 8-K
- Nov 4, 2025Zoetis Announces Third Quarter 2025 Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry